Benjamin Machinas Beneski, SVP, Chief Technical Officer at Allogene Therapeutics, Inc. (ALLO), sold 786 shares at $1.22 ($959) on 2025-11-17, disclosed to the SEC on 2025-11-19.
Open-market sale of $959 ALLO by SVP, Chief Technical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ALLO | SELL | 2026-03-04 | $19K | — | Filing → |
| ALLO | SELL | 2026-02-04 | $13K | — | Filing → |
| ALLO | SELL | 2025-03-18 | $11K | — | Filing → |